Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volatile Anesthetic Protection of Renal Transplants 2
2016-000992-26Phase 3Active
- Sponsor
- University Medical Center Groningen
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sevoflurane and propofol in end-stage kidney disease (ESKD) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Acute rejection episodes. Started May 2016; status: active.
02
Drugs
sevofluranepropofol
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2016-000992-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000992-26.